Lenvatinib and Pembrolizumab With or Without BCAA in Unresectable HCC
Clinical trial NCT07412054 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07412054
- Sponsor
- Fudan University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-01
- Primary completion
- 2027-06-01
- Enrollment
- 234
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.